Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Fallon

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Chemical Senses|April 29, 2015
Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discriminationArielle Schilit Nitenson, Emily E Stackpole, Torrey L S Truszkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx miceAlison R Amenta, Atilgan Yilmaz, Sasha Bogdanovich, et al.
Skeletal Muscle|January 4, 2024
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingDiego Jaime, Lauren A Fish, Laura A Madigan, et al.
Science Signaling|September 8, 2016
MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cellsAtilgan Yilmaz, Chandramohan Kattamuri, Rana N Ozdeslik, et al.
Human Molecular Genetics|June 3, 2005
AP-2alpha selectively regulates fragile X mental retardation-1 gene transcription during embryonic developmentJae H Lim, Anne B Booker, Ting Luo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2006
Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOSMary Lynn Mercado, Alison R Amenta, Hiroki Hagiwara, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
Orphanet Journal of Rare Diseases|June 25, 2015
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug AdministrationPat Furlong, John F P Bridges, Lawrence Charnas, et al.
Journal of Cellular Physiology|August 3, 2006
Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during developmentMichael S Rafii, Hiroki Hagiwara, Mary Lynn Mercado, et al.
Human Molecular Genetics|January 14, 2017
Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brainsMichael R Akins, Hanna E Berk-Rauch, Kenneth Y Kwan, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Chemical Senses|April 29, 2015
Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discriminationArielle Schilit Nitenson, Emily E Stackpole, Torrey L S Truszkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx miceAlison R Amenta, Atilgan Yilmaz, Sasha Bogdanovich, et al.
Skeletal Muscle|January 4, 2024
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingDiego Jaime, Lauren A Fish, Laura A Madigan, et al.
Science Signaling|September 8, 2016
MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cellsAtilgan Yilmaz, Chandramohan Kattamuri, Rana N Ozdeslik, et al.
Human Molecular Genetics|June 3, 2005
AP-2alpha selectively regulates fragile X mental retardation-1 gene transcription during embryonic developmentJae H Lim, Anne B Booker, Ting Luo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2006
Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOSMary Lynn Mercado, Alison R Amenta, Hiroki Hagiwara, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
Orphanet Journal of Rare Diseases|June 25, 2015
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug AdministrationPat Furlong, John F P Bridges, Lawrence Charnas, et al.
Journal of Cellular Physiology|August 3, 2006
Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during developmentMichael S Rafii, Hiroki Hagiwara, Mary Lynn Mercado, et al.
Human Molecular Genetics|January 14, 2017
Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brainsMichael R Akins, Hanna E Berk-Rauch, Kenneth Y Kwan, et al.
Pageof 4